Chris Amos

Chris Amos is a Professor and Chief in the Department of Epidemiology & Population Science within the Department of Medicine at Baylor College of Medicine. He also serves as Director for the Institute of Clinical and Translational Medicine and Associate Director of Quantitative Science at the Dan L Duncan Comprehensive Cancer Center in Houston, Texas.

Education:

• PhD in Biometry, LSU Medical Center, New Orleans (1988)
• MS in Biometry, LSU Medical Center, New Orleans (1985)
• BA in Mathematics, Reed College, Portland, Oregon
• Postdoctoral Fellowship in Family Studies and Environmental Epidemiology, National Cancer Institute, Bethesda, MD (1990)

Dr. Amos specializes in genetic epidemiology, biostatistics, and population health, with a strong focus on cancer genomics and translational research. His work integrates quantitative methods with large-scale genetic data to understand disease susceptibility and environmental interactions. He has played a key role in advancing informatics infrastructure for research and education at Baylor.

Throughout his career, Dr. Amos has held numerous leadership and advisory roles in national and international scientific organizations. He was President and later Secretary/Treasurer of the International Genetic Epidemiology Society, and has served on advisory boards at the National Institute for Environmental Health Sciences and the University of Vermont Cancer Center. His contributions have been recognized through endowed professorships and faculty achievement awards.

Scientific Awards and Honors:

• Leadership Award, International Genetic Epidemiology Society (2003)
• President, International Genetic Epidemiology Society (2002)
• Annie Laurie Howard Endowed Professor (2006–2012)
• Ashbel Smith Professor (2001–2005)
• The Margaret and James A Elkins, Jr. Faculty Achievement Award (2000)
• Jeffry Trent Lecture in Genomics, NHGRI (2011)
• Board of Scientific Counselors, NIEHS (2015)
• Board of Advisors, University of Vermont Cancer Center (2017)

Dr. Amos has been actively involved in academic governance and training programs, serving on admissions subcommittees and informatics steering teams. He has led initiatives in clinical and translational research infrastructure, contributing to the development of data systems that support education and discovery. Although specific grant details are not listed, his leadership roles suggest substantial funding and collaborative projects.

He is affiliated with key research entities including the Dan L Duncan Comprehensive Cancer Center and the Institute of Clinical and Translational Medicine, where he drives quantitative science and translational research efforts.